Companies
Universal Robots
documented a 74 percent reduction in biomanufacturing costs for cell and gene therapy production using a robotic cluster built on collaborative arms, illustrating the measured economics of cobot deployment in regulated biomanufacturing.
- Country
- Denmark
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cobots for bioproduction | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.